Mandate

Vinge advises Investor on Agnafit Bidco’s public offer for Sobi

September 02, 2021 Capital Markets and Public M&A

Agnafit Bidco has announced a public offer to the shareholders of Swedish Orphan Biovitrum AB (publ).

The total value of the offer is approximately SEK 69.4 billion.

Vinges team mainly includes public M&A partner Erik Sjöman that advises Investor AB (publ), Sobi’s largest shareholder.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023